Purdue's abuse-resistant OxyContin approved in US
This article was originally published in Scrip
Executive Summary
The US FDA has approved Purdue Pharma's reformulation of OxyContin (oxycodone HCl controlled-release 10mg, 15mg, 20mg, 30mg, 40mg, 60mg and 80mg tablets) that has been designed to be less susceptible to misuse and abuse. It is indicated for the management of moderate-to-severe pain where a continuous, around–the-clock opioid analgesic is needed for an extended period of time.